Whitehawk Therapeutics, Inc. — Director's Dealing 2020

Mar 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aerpio Pharmaceuticals, Inc. (ARPO)
CIK: 0001422142
Period of Report: 2020-03-16

Reporting Person: Marek Regina (Vice President of Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-16	Stock Option (Right to Buy)	$0.5201	A	93000	Acquired	2030-03-16	Common Stock (93000)	Direct

Footnotes

F1: Options exercisable as to 1/4th on March 16, 2021 and an additional 1/48th monthly thereafter until March 16, 2024.